REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

HBM Holdings Limited (和铂医药控股有限公司) (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: HBM Holdings Limited Profile Updated: October 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

HBM Holdings Limited focuses on innovative therapies in the field of tumor immunology and immune diseases. The company's products are mainly used in immune thrombocytopenia, thyroid associated ophthalmopathy, myasthenia gravis, neuromyelitis optica spectrum diseases. The company was established in 2016 and headquartered in Shanghai City, China.

Headquarters
12Th Floor, Tower A, Fenglin International Plaza Phase Ii, 420 Fenglin Road, Xuhui District
Shanghai; Shanghai;

Contact Details: Purchase the HBM Holdings Limited (和铂医药控股有限公司) report to view the information.

Website: http://www.harbourbiomed.com

Basic Information
Total Employees:
Purchase the HBM Holdings Limited (和铂医药控股有限公司) report to view the information.
Outstanding Shares:
Purchase the HBM Holdings Limited (和铂医药控股有限公司) report to view the information.
Registered Capital:
Purchase the HBM Holdings Limited (和铂医药控股有限公司) report to view the information.
Financial Auditors:
Purchase the HBM Holdings Limited (和铂医药控股有限公司) report to view the information.
Incorporation Date:
July 20, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
12.18%
Purchase this report to view the information.
8.93%
Purchase this report to view the information.
7.86%
Purchase this report to view the information.
6.59%
Purchase this report to view the information.
0.15%
Subsidiaries
Harbour Antibodies Bv (Netherlands)
100%
Harbour Biomed Holdings Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after HBM Holdings Limited (和铂医药控股有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
332.21%▲
Total operating revenue
299.55%▲
Operating profit (EBIT)
2191.33%▲
EBITDA
1409.64%▲
Net Profit (Loss) for the Period
5183.38%▲
Total assets
73.95%▲
Total equity
131.95%▲
Operating Profit Margin (ROS)
59.58%▲
Net Profit Margin
66.16%▲
Return on Equity (ROE)
24.6%▲
Debt to Equity Ratio
-31.08%▼
Quick Ratio
2.58%▲
Cash Ratio
2.43%▲

Similar companies

Chongqing Zhifei Biological Products Co.,Ltd.
 
Shandong Lukang Pharmaceutical Co.,Ltd.
Autobio Diagnostics Co., Ltd
 
Hualan Biological Engineering,Inc.
Cathay Biotech Inc.
 
Shenzhen Kangtai Biological Products Co.,Ltd.
Genor Biopharma Holdings Limited
 
Qyuns Therapeutics Co. Ltd.
Wuhan Yzy Biopharma Co. Ltd.
 
Laekna, Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo